Mr. Paul Duffy reports

AI/ML INNOVATIONS ANNOUNCES COMPLETION OF SHARE ISSUANCE

AI-ML Innovations Inc. has completed its previously announced shares-for-debt issuance with certain service providers of the company pursuant to which the company has issued an aggregate of 7,744,062 common shares at a deemed price of five cents per subject share totalling $387,203 in consideration of past services and satisfaction of outstanding indebtedness.

The subject shares are subject to a statutory hold period expiring on Feb. 10, 2027.

Insiders of the company expect to purchase, directly or indirectly, an aggregate of 4,900,001 subject shares, as a result of which the issuance is a related-party transaction under Multilateral Instrument 61-101 (Protection of Minority Security Holders in Special Transactions). The company is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 pursuant to the exemptions contained in sections 5.5(b) and 5.7(1)(a) of MI 61-101 on the basis that the company is listed on the Canadian Securities Exchange, and neither the fair market value (as determined under MI 61-101) of the subject matter of, nor the fair market value of the consideration for, the subject shares, insofar as it involves the related parties, exceeded 25 per cent of the company's market capitalization (as determined under MI 61-101).

About AI-ML Innovations Inc.

AI-ML is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. Its proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable insights -- supporting earlier diagnosis, personalized treatment and more effective care.

AI-ML's common shares trade on the Canadian Securities Exchange, the OTCQB Venture Market and the Frankfurt Stock Exchange.

We seek Safe Harbor.